Skip to main content

Gains in Heart Health Only Experienced by Higher-Income Populations

Medically reviewed by Carmen Pope, BPharm. Last updated on April 19, 2024.

By Lori Solomon HealthDay Reporter

FRIDAY, April 19, 2024 -- Only higher-income populations experienced improvements in cardiovascular health from 1988 to 2018, according to a study published online April 3 in Circulation: Cardiovascular Quality and Outcomes.

Nicholas K. Brownell, M.D., from the University of California, Los Angeles, and colleagues examined 30-year trends in cardiovascular health by income. The analysis included data from 26,633 participants (aged 40 to 75 years) in the U.S. National Health and Nutrition Examination Survey (1988 to 2018) stratified by poverty-to-income ratio (PIR) category.

The researchers found that from 1988-1994 to 2015-2018, the mean 10-year pooled cohort equation (PCE) risk improved from 7.8 to 6.4 percent. However, the improvement was limited to the two highest-income categories (10-year PCE risk for PIR 5: 7.7 to 5.1 percent; PIR 3 to 4.99: 7.6 to 6.1 percent). For the lowest-income category, the 10-year PCE risk did not significantly change (PIR <1: 8.1 to 8.7 percent). Over time, the relative inequity in 10-year PCE risk increased (1988 to 1994 PIR <1 was 6 percent higher than PIR 5; by 2015 to 2018, inequity increased to 70 percent). When accounting for all income categories, the achievement index was consistently higher than the mean 10-year PCE risk, indicating the poor persistently had a greater share of adverse health, despite overall achievement index improvement (8.0 to 7.1 percent).

"This study shows we need to be looking long and hard about ways to improve access to health care and other social determinants of health that play a role in higher cardiovascular risks for low-income households," coauthor Adam Richards, M.D., Ph.D., M.P.H., from George Washington University in Washington, D.C., said in a statement.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM

FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...

DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD

WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...

Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease

TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.